JP2023548399A5 - - Google Patents
Info
- Publication number
- JP2023548399A5 JP2023548399A5 JP2023527452A JP2023527452A JP2023548399A5 JP 2023548399 A5 JP2023548399 A5 JP 2023548399A5 JP 2023527452 A JP2023527452 A JP 2023527452A JP 2023527452 A JP2023527452 A JP 2023527452A JP 2023548399 A5 JP2023548399 A5 JP 2023548399A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- sequence described
- antibody containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063109814P | 2020-11-04 | 2020-11-04 | |
| US63/109,814 | 2020-11-04 | ||
| US202063113920P | 2020-11-15 | 2020-11-15 | |
| US63/113,920 | 2020-11-15 | ||
| PCT/US2021/057209 WO2022098570A1 (en) | 2020-11-04 | 2021-10-29 | Novel bifunctional multispecific antagonists capable of inhibiting multiple ligands of tgf-beta family and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023548399A JP2023548399A (ja) | 2023-11-16 |
| JP2023548399A5 true JP2023548399A5 (cg-RX-API-DMAC7.html) | 2024-11-08 |
Family
ID=81458297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023527452A Pending JP2023548399A (ja) | 2020-11-04 | 2021-10-29 | Ｔｇｆ－ベータファミリーの複数のリガンドを阻害する能力を有する新規の二機能性多特異性アンタゴニストおよびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240343788A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4240388A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023548399A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230117348A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021376241A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3196443A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023004726A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022098570A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025043075A1 (en) * | 2023-08-24 | 2025-02-27 | The Johns Hopkins University | Methods of treating myocardial infarction, ischemia, and ischemia reperfusion injury |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA41920B1 (fr) * | 2015-04-06 | 2021-05-31 | Acceleron Pharma Inc | Protéines de fusion de récepteur type i et type ii à bras unique et leurs utilisations |
| EP3576773B1 (en) * | 2017-02-01 | 2023-10-18 | Acceleron Pharma Inc. | Tgf beta and actrii antagonists for use in treating leukemia |
| US12103959B2 (en) * | 2018-05-03 | 2024-10-01 | Acceleron Pharma Inc. | Multispecific binders of TGFBeta-superfamily ligands and uses thereof |
| CA3103427A1 (en) * | 2018-06-15 | 2019-12-19 | Acceleron Pharma Inc. | Bi-and tri-functional fusion proteins and uses thereof |
-
2021
- 2021-10-29 CA CA3196443A patent/CA3196443A1/en active Pending
- 2021-10-29 WO PCT/US2021/057209 patent/WO2022098570A1/en not_active Ceased
- 2021-10-29 AU AU2021376241A patent/AU2021376241A1/en active Pending
- 2021-10-29 US US18/034,499 patent/US20240343788A1/en active Pending
- 2021-10-29 MX MX2023004726A patent/MX2023004726A/es unknown
- 2021-10-29 KR KR1020237018740A patent/KR20230117348A/ko active Pending
- 2021-10-29 JP JP2023527452A patent/JP2023548399A/ja active Pending
- 2021-10-29 EP EP21889869.0A patent/EP4240388A4/en active Pending